Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.
Saved in:
| Title: | Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab. |
|---|---|
| Authors: | Topalian SL; Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brahmer JR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Gettinger SN; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut., Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor., McDermott DF; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sosman JA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; now with the Department of Medicine (Hematology and Oncology), Northwestern University Medical Center, Chicago, Illinois., Atkins MB; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.; now with the Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia., Leming PD; The Christ Hospital Cancer Center, Cincinnati, Ohio., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee., Antonia SJ; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Carvajal RD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.; now with the Department of Medicine, Columbia University Irving Medical Center, New York, New York., McHenry MB; Bristol-Myers Squibb, Princeton, New Jersey., Hosein F; Bristol-Myers Squibb, Princeton, New Jersey., Harbison CT; Bristol-Myers Squibb, Princeton, New Jersey., Grosso JF; Bristol-Myers Squibb, Princeton, New Jersey., Sznol M; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut. |
| Source: | JAMA oncology [JAMA Oncol] 2019 Oct 01; Vol. 5 (10), pp. 1411-1420. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31343665 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Topalian+SL%22">Topalian SL</searchLink>; Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Hodi+FS%22">Hodi FS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Brahmer+JR%22">Brahmer JR</searchLink>; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Smith+DC%22">Smith DC</searchLink>; Department of Internal Medicine, University of Michigan, Ann Arbor.<br /><searchLink fieldCode="AU" term="%22McDermott+DF%22">McDermott DF</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Powderly+JD%22">Powderly JD</searchLink>; Carolina BioOncology Institute, Huntersville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Sosman+JA%22">Sosman JA</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; now with the Department of Medicine (Hematology and Oncology), Northwestern University Medical Center, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Atkins+MB%22">Atkins MB</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.; now with the Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Leming+PD%22">Leming PD</searchLink>; The Christ Hospital Cancer Center, Cincinnati, Ohio.<br /><searchLink fieldCode="AU" term="%22Spigel+DR%22">Spigel DR</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Antonia+SJ%22">Antonia SJ</searchLink>; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Drilon+A%22">Drilon A</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Wolchok+JD%22">Wolchok JD</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Carvajal+RD%22">Carvajal RD</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.; now with the Department of Medicine, Columbia University Irving Medical Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22McHenry+MB%22">McHenry MB</searchLink>; Bristol-Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Hosein+F%22">Hosein F</searchLink>; Bristol-Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Harbison+CT%22">Harbison CT</searchLink>; Bristol-Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Grosso+JF%22">Grosso JF</searchLink>; Bristol-Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Sznol+M%22">Sznol M</searchLink>; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2019 Oct 01; Vol. 5 (10), pp. 1411-1420. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31343665 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2019.2187 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1411 Titles: – TitleFull: Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Topalian SL – PersonEntity: Name: NameFull: Hodi FS – PersonEntity: Name: NameFull: Brahmer JR – PersonEntity: Name: NameFull: Gettinger SN – PersonEntity: Name: NameFull: Smith DC – PersonEntity: Name: NameFull: McDermott DF – PersonEntity: Name: NameFull: Powderly JD – PersonEntity: Name: NameFull: Sosman JA – PersonEntity: Name: NameFull: Atkins MB – PersonEntity: Name: NameFull: Leming PD – PersonEntity: Name: NameFull: Spigel DR – PersonEntity: Name: NameFull: Antonia SJ – PersonEntity: Name: NameFull: Drilon A – PersonEntity: Name: NameFull: Wolchok JD – PersonEntity: Name: NameFull: Carvajal RD – PersonEntity: Name: NameFull: McHenry MB – PersonEntity: Name: NameFull: Hosein F – PersonEntity: Name: NameFull: Harbison CT – PersonEntity: Name: NameFull: Grosso JF – PersonEntity: Name: NameFull: Sznol M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2019 Oct 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 5 – Type: issue Value: 10 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |